Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Balassa Laboratories, Inc.
FDA Inspection
•Balassa Laboratories, Inc.•February 19, 2013

Balassa Laboratories, Inc. – FDA Inspection, Feb 19, 2013

Record Details

This FDA Inspection record concerns Balassa Laboratories, Inc., with an inspection on February 19, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Balassa Laboratories, Inc.
Inspection Date
February 19, 2013
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 5663f49f-622a-4e28-babb-64e4299eba72

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
819218
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

12
  1. 21 CFR 211.188(b)(4)Weights and measures of components used
  2. 21 CFR 211.84(d)(3)Container/Closure Written Test Procedure
  3. 21 CFR 211.160(b)Scientifically sound laboratory controls
  4. 21 CFR 211.198(a)Complaint Handling Procedure
  5. 21 CFR 211.84(d)(2)Reports of Analysis (Components)
  6. 21 CFR 211.170(b)Annual visual exams of drug products
  7. 21 CFR 211.160(b)(3)Drug products - samples representative, identified properly
  8. 21 CFR 211.122(a)Written procedures describing in detail
  9. 21 CFR 211.166(a)Lack of written stability program
  10. 21 CFR 211.22(d)Procedures not in writing, fully followed

Showing 10 of 12 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Balassa Laboratories, Inc.

4
DateClassificationOfficeProject area
August 21, 2026VAIFlorida District OfficeFoodborne Biological Hazards
April 7, 2023VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
April 23, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
April 25, 2014VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Balassa Laboratories, Inc.
  • FDA Inspection 1332070 - 2026-08-21
  • FDA Inspection 1202446 - 2023-04-07
  • FDA Inspection 1049200 - 2018-04-23
  • FDA Inspection 876075 - 2014-04-25

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Balassa Laboratories, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.